本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Oric Pharmaceuticals Inc.

9.24
-0.3900-4.05%
盘后:9.06-0.1800-1.95%19:46 EDT
成交量:105.01万
成交额:970.88万
市值:7.87亿
市盈率:-4.91
高:9.66
开:9.64
低:9.03
收:9.63
52周最高:14.67
52周最低:3.90
股本:8,521.84万
流通股本:5,545.50万
量比:1.37
换手率:1.89%
股息:- -
股息率:- -
每股收益(TTM):-1.8805
每股收益(LYR):-1.8335
净资产收益率:-48.45%
总资产收益率:-30.87%
市净率:3.58
市盈率(LYR):-5.04
分时
5日
日K
周K
月K
季K
年K
1分
5分
10分
15分
30分
1小时
2小时
更多
分时
5日
日K
周K
月K
季K
年K
1分
5分
10分
15分
30分
1小时
2小时
2024/11/12

重要事件披露

Form 8-K - Current report
2024/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/03/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/01

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/31

SEC问询函

Form CORRESP - Correspondence
2024/01/30

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/25

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

如果下载按钮点击无跳转,请点击右上角菜单选择 “在浏览器打开”